Prevalence of sarcopenia and associated factors in institutionalised older adult patients

被引:40
作者
Bravo-Jose, Patricia [1 ]
Moreno, Elena [2 ]
Espert, Minerva [3 ]
Romeu, Maria [3 ]
Martinez, Pilar [4 ]
Navarro, Concepcion [2 ]
机构
[1] RPMD Burriana, Serv Pharm, Albert Einstein 1, Burriana 12530, Castellon, Spain
[2] Generalitat Valenciana, Ctr Management & Elderly Program Dept, Valencia, Spain
[3] RPMD La Florida, Serv Pharm, Alicante, Spain
[4] RPMD La Canada, Serv Pharm, Valencia, Spain
关键词
Sarcopenia; Nursing home; Institutionalised older adult patients;
D O I
10.1016/j.clnesp.2018.05.008
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 [营养与食品卫生学];
摘要
Background & aims: Sarcopenia is a syndrome characterised by a progressive and generalised loss of skeletal muscle mass and strength with a risk of adverse outcomes such as physical disability, poor quality of life and death. The main aim of the present study was to establish the prevalence of sarcopenia using EWGSOP-defined criteria in institutionalised older adult patients in long-term care institutions. A secondary purpose was to identify the risk factors that develop Sarcopenia in this population. Methods: A Multicentre cross-sectional study was conducted in 334 institutionalised older adult patients, where the prevalence of sarcopenia and its relation with certain risk factors were measured. Physical performance was measured by gait speed, muscle strength measured by a handheld dynamometer and skeletal muscle mass measured using bioimpedance analysis. Different variables were collected: body mass index (BMI), diseases documented in the clinical record, the numbers of falls, the level of activity and functional ability. Results: Two hundred eighty five individuals were included. According the EWGSOP algorithm and the cut-off points proposed by Masanes et al. for the Spanish population, 118 (41.4%) participants presented sarcopenia, of which 32 patients (27%) suffered from moderate sarcopenia, 78 patients (66%) were identified as severe sarcopenia patients and only 8 (7%) were classified as sarcopenic obesity. More female residents (96 females (81.4%) vs. 22 males (18.6%), p < 0.0001) tended to be sarcopenic. Patients diagnosed with sarcopenia tended to be more functionally impaired and had a more unfavourable BMI than those who were not sarcopenic (Barthel score 40.93 vs, 49.22, p = 0.0034 and BMI 23.57 vs, 27.61, p < 0.0001). Results from regression analysis indicated that those older than 85 years old (OR 2.495, 95% CI 1.401-4.441), the female gender, (OR 3.215, 95% CI 1.635-6.324) and whose BMI was lower than 22 (OR 5.973, 95% CI 2.932-12.165) appeared to be associated with sarcopenia, whereas the Barthel Index and other factors were not. Conclusion: The present study suggests that sarcopenia is highly prevalent in patients living in long-term care institutions, especially in female patients. Our findings support that the muscle mass was negatively associated with poor nutritional status and poor capacity to develop basic activities of daily living that indicates high dependency of these patients and high necessity of care. (c) 2018 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:113 / 119
页数:7
相关论文
共 36 条
[2]
Prevalence and associated factors of sarcopenia in older adults with intellectual disabilities [J].
Bastiaanse, Luc P. ;
Hilgenkamp, Thessa I. M. ;
Echteld, Michael A. ;
Evenhuis, Heleen M. .
RESEARCH IN DEVELOPMENTAL DISABILITIES, 2012, 33 (06) :2004-2012
[3]
Batzan JJ, 1993, REV ESP GERIATR GERO, V28, P32
[4]
Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group [J].
Bauer, Juergen ;
Biolo, Gianni ;
Cederholm, Tommy ;
Cesari, Matteo ;
Cruz-Jentoft, Alfonso J. ;
Morley, John E. ;
Phillips, Stuart ;
Sieber, Cornel ;
Stehle, Peter ;
Teta, Daniel ;
Visvanathan, Renuka ;
Volpi, Elena ;
Boirie, Yves .
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2013, 14 (08) :542-559
[5]
Effects of a Vitamin D and Leucine-Enriched Whey Protein Nutritional Supplement on Measures of Sarcopenia in Older Adults, the PROVIDE Study: A Randomized, Double-Blind, Placebo-Controlled Trial [J].
Bauer, Juergen M. ;
Verlaan, Sjors ;
Bautmans, Ivan ;
Brandt, Kirsten ;
Donini, Lorenzo M. ;
Maggio, Marcello ;
McMurdo, Marion E. T. ;
Mets, Tony ;
Seal, Chris ;
Wijers, Sander L. ;
Ceda, Gian Paolo ;
De Vito, Giuseppe ;
Donders, Gilbert ;
Drey, Michael ;
Greig, Carolyn ;
Holmback, Ulf ;
Narici, Marco ;
McPhee, Jamie ;
Poggiogalle, Eleonora ;
Power, Dermot ;
Scafoglieri, Aldo ;
Schultz, Ralf ;
Sieber, Cornel C. ;
Cederholm, Tommy .
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2015, 16 (09) :740-747
[6]
Estimation of sarcopenia prevalence using various assessment tools [J].
Beaudart, C. ;
Reginster, J. Y. ;
Slomian, J. ;
Buckinx, F. ;
Dardenne, N. ;
Quabron, A. ;
Slangen, C. ;
Gillain, S. ;
Petermans, J. ;
Bruyere, O. .
EXPERIMENTAL GERONTOLOGY, 2015, 61 :31-37
[7]
Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials [J].
Bischoff-Ferrari, H. A. ;
Dawson-Hughes, B. ;
Staehelin, H. B. ;
Orav, J. E. ;
Stuck, A. E. ;
Theiler, R. ;
Wong, J. B. ;
Egli, A. ;
Kiel, D. P. ;
Henschkowski, J. .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 :843
[8]
Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752
[9]
Burgos Pelaez R, 2006, ENDOCRINOL NUTR, V53, P335
[10]
Chevalier S, 2008, J NUTR HEALTH AGING, V12, P721